Oxford vaccine is taking the green light in Britain

The vaccine was developed by AstraZeneca in cooperation with the University of Oxford

The British Medicines Agency has given the green light for a new anti-corona virus vaccine developed by AstraZeneca in cooperation with the University of Oxford, through which the authorities intend to accelerate the vaccination campaign that it started in early December.

A spokesperson for the Ministry of Health said, “The government agreed (Wednesday) to the recommendation of the Medicines and Health Products Regulatory Agency to allow the use of the Oxford University / AstraZeneca vaccine against” the emerging corona virus.

The government said in a statement: "The National Health Services Authority will now begin making intensive preparations, in the implementation phase, to launch the Oxford University vaccine and AstraZeneca."

It is noteworthy that the vaccine is the second to be approved for use in Britain.

A vaccine produced by Pfizer and Biontec was the first vaccine to get the green light in Britain by the British Medicines and Healthcare Products Regulatory Agency on December 2, and it began to be used for people at greatest risk and the elderly the following week.

The statement adds: "With the adoption of two vaccines now, we will be able to vaccinate a greater number of people at greatest risk, protect them from disease and reduce deaths and hospital overload."

Follow our latest local and sports news, and the latest political and economic developments via Google news